Around 300 million people worldwide are visually impaired. Retinitis pigmentosa (RP) and age-related macular degeneration (AMD), involving deterioration of retinal photoreceptors-cells, are the leading causes of partial or ...
Dec 14, 2020
0
0
"Wet" age-related macular degeneration (AMD) is one of the most common causes of irreversible vision loss in the elderly, and it occurs when abnormal and leaky blood vessels form in the retina, in part due to inflammation. ...
Dec 11, 2020
0
76
An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial ...
Dec 11, 2020
0
863
A new study by scientists at the University of Southampton has made a breakthrough that could help the search for treatments against age related sight loss.
Dec 2, 2020
0
4
Public health services across the world are failing to meet targets to reduce avoidable sight loss, according to a new study published today (1 December) in The Lancet Global Health.
Dec 1, 2020
0
1
Vision loss related to aging or inherited genetic disease, such as age-related macular degeneration and retinitis pigmentosa (RP), respectively, is estimated to impact 16 million people worldwide and is often caused by defects ...
Nov 25, 2020
0
3
Eye research charity Fight for Sight has announced funding for a ground-breaking stem cell research study which could reverse sight loss for people with macular diseases such as age-related macular degeneration and juvenile ...
Nov 10, 2020
0
238
(HealthDay)—For initially healthy men and women, supplementation with vitamin D3 and marine omega-3 fatty acids have no significant impact on age-related macular degeneration (AMD) incidence or progression, according to ...
Oct 30, 2020
2
191
Scientists at Scripps Research have uncovered a potential new strategy for treating eye diseases that affect millions of people around the world, often resulting in blindness.
Oct 27, 2020
0
76
A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy. The National Eye Institute, part of the National Institutes of Health, ...
Oct 22, 2020
0
196
